Chinook investor relations
Web23 hours ago · Chinook assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release. Contact: Noopur Liffick Senior Vice President, Investor Relations & Corporate Communications [email protected] [email protected] WebChinook Therapeutics (Nasdaq: KDNY) is a clinical-stage biotechnology company developing precision medicines for kidney diseases. Chinook’s product candidates are being investigated in rare ...
Chinook investor relations
Did you know?
WebApr 13, 2024 · Chinook Therapeutics, Inc. SEATTLE, April 13, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused … Web1 day ago · Chinook Therapeutics, Inc. (Exact name of registrant as specified in its charter) ... Investor Relations & Corporate Communications [email protected] [email protected] Apr 10, 2024 COMTEX ...
WebMay 25, 2024 · SEATTLE, May 24, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY) today announced the pricing of its underwritten public offering of … Web1 day ago · Chinook is leveraging insights from kidney single cell RNA sequencing and large CKD patient cohorts that have been comprehensively panomically phenotyped, with retained biosamples and prospective ...
WebApr 11, 2024 · Chinook Therapeutics, Inc. SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and ... Web2 days ago · To access the audio webcasts and subsequent archived recording of these and other company presentations, please visit the Investors section of Chinook’s website. …
WebFeb 27, 2024 · Chinook assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release. Contact: Noopur Liffick
Web2 days ago · SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development … hematologista santa mariaWebApr 11, 2024 · Cautionary Note on Forward-Looking Statements Certain of the statements made in this press release are forward looking, including those relating to Chinook’s business, future operations ... hematologista valença rjWeb23 hours ago · Chinook assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise, after the date of this … hematologist hamilton ontarioWebApr 11, 2024 · Chinook Therapeutics, Inc. SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused … hematologista vila velhaWebNoopur Liffick is Senior Vice President of Investor Relations and Corporate Communications at Chinook Therapeutics. With over 17 years of investor relations, communications and financial services experience in the healthcare industry and over $350 million in capital raised, Noopur has established a proven track record of managing … hematologist in jacksonville ncWeb1 day ago · Chinook Therapeutics, Inc. (Exact name of registrant as specified in its charter) ... Investor Relations & Corporate Communications [email protected] … hematologist hays ksWebApr 11, 2024 · Investor Relations ... About Chinook Therapeutics, Inc. Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing precision medicines for kidney diseases. Chinook’s ... hematologist at johns hopkins